Transforming growth factor-β1 and lung allograft fibrosis

European Journal of Cardio-thoracic Surgery

Volumn 13, Issue 4, 1998, Pages 424-430

  El Gamel, Ahmed ^a   Awad, Mohammed ^b   Sim, Ewan ^a   Hasleton, Philip ^a   Yonan, Nizar ^a   Egan, Jim ^a   Deiraniya, Abdul ^a   Hutchinson, Ian V ^c  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Allograft; Lung transplantation; Transforming growth factor 1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ALLOGRAFT; ARTICLE; CARDIOPULMONARY BYPASS; EXTRACELLULAR MATRIX; FEMALE; GENOTYPE; GRAFT REJECTION; HUMAN; INFECTION RISK; LUNG FIBROSIS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEPTICEMIA;

ADOLESCENT; ADULT; DNA PROBES; FIBROSIS; GENOTYPE; GRAFT REJECTION; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG TRANSPLANTATION; MIDDLE AGED; TRANSFORMING GROWTH FACTOR BETA; TRANSPLANTATION, HOMOLOGOUS;

EID: 0011215880     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(98)00048-7     Document Type: Article

References (18)

1. [1] Hirabayashi T, Demertzis S, Schafers J, Hoshino K, Nashan B. Chronic rejection in lung allografts: immunohistological analysis of fibrogenesis. Transplant Int 1996;9(Suppl 1):S293-5.
2. [2] Yousem SA, Suncan SR, Ohori NP, Sonmez-Alpan E. Architectural remodeling of lung allografts in acute and chronic rejection (see comments). Arch Pathol Lab Med 1992;116(11):1175-80.
3. [3] Crystal R. Interstitial lung disease. In: Wyngaarden JB, editor. Cecil Text Book of Medicine. Philadelphia, PA: Saunders, 1980:421-35.
4. [4] Brigham K, Meyrick B. Interactions of granulocytes with the lungs. Circ Res 1985;54:623-35.
5. [5] McCullough B, Collins J. Bleomycin-induced diffuse interstitial pulmonary fibrosis in baboons. J Clin Invest 1978;61:79-88.
6. [6] Sitrin RG, Brubaker PG, Fantone JC. Tissue fibrin deposition during acute lung injury in rabbits and its relationship to pro coagulant and fibrinolytic activities. Am Rev Respir Dis 1987;135:930-6.
7. [7] Colvin RB, Robbin RO, Verderber EL, Lanigan JM. Cell surface fibrinogen-fibrin receptors on cultured human fibroblasts. Lab Invest 1979;41:464-72.
8. [8] Idell S, Giles C, Fair DS, Thrall RS. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am J Pathol 1989;135:387-99.
9. [9] Khalil N, Greenberg AH. The role of TGF-beta in pulmonary fibrosis. Ciba Found Symp 1991;157:194-211.
10. [10] Martinet Y, Menard O, Vaillant P, Vignaud JM, Martinet N. Cytokines in human lung fibrosis. Arch Toxicol 1996;18(Supplement):127-39.
11. [11] Cooper JD. The evolution of techniques and indications for lung transplantation. Ann Surg 1990;212(3):249-56.
12. [12] Patterson GA. Double lung transplantation. Clin Chest Med 1990;11(2):227-33.
13. [13] Sundaresan S, Trachiotis GD, Aoe M, Patterson GA, Cooper JD. Donor lung procurement: assessment and operative technique (see comments). Ann Thorac Surg 1993;56(6):1409-13.
14. [14] Trulock EP. Management of lung transplant rejection. Chest 1993;103(5):1566-76.
15. [15] Ashchroft T, Simpson J, Timbrell V. Simple method of estimating severity of pulmonary fibrosis on a numerical scale. J Clin Pathol 1988;41:467-70.
16. [16] Cherniack M, Colby TV, Flint A, BAL Cooperative Group Steering Committee. Quantitative assessment of lung pathology in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1991;144:892-900.
17. [17] Lendrum A. The staining of eosinophil, polymorphl and enterochromassin cells in histology sections. J Pathol Bacteriol 1944;C56:441.
18. [18] Bienkowski RS, Gotkin MG. Control of collagen deposition in mammalian lung. Proc Soc Exp Biol Med 1995;209(2):118-40.